Purchase of 1,250,000 shares of common stock at $4.00 per share in the 2024 Private Placement
| Officer | Age | Joined | 2026 pay | Source |
|---|---|---|---|---|
|
Nevan Charles Elam
Also a director
Chief Executive Officer and Acting Chairman of the Board
|
59 | Not stated | $5,711,410 | |
|
Daron Evans
Chief Financial and Business Officer
|
53 | 2024 | $2,285,466 | |
|
Brian Roberts
Chief Medical Officer
|
52 | 2015 | $2,564,957 | |
|
Sunil Karnawat
Chief Commercial Officer
|
59 | 2025 | $2,623,909 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Purchase of 1,250,000 shares of common stock at $4.00 per share in the 2024 Private Placement
Purchase of 1,230,769 shares of common stock at $3.25 per share in the 2025 Private Placement; aggregate proceeds of this and the Nerissa Kreher purchase stated as $4.0 million
Purchase of 3,076 shares of common stock at $3.25 per share in the 2025 Private Placement
Loading...